GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (XPAR:ERF) » Definitions » EV-to-Revenue
中文

Eurofins Scientific SE (XPAR:ERF) EV-to-Revenue : 2.10 (As of Apr. 24, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Eurofins Scientific SE EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Eurofins Scientific SE's enterprise value is €13,674 Mil. Eurofins Scientific SE's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €6,515 Mil. Therefore, Eurofins Scientific SE's EV-to-Revenue for today is 2.10.

The historical rank and industry rank for Eurofins Scientific SE's EV-to-Revenue or its related term are showing as below:

XPAR:ERF' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.8   Med: 3.08   Max: 4.94
Current: 2.1

During the past 13 years, the highest EV-to-Revenue of Eurofins Scientific SE was 4.94. The lowest was 1.80. And the median was 3.08.

XPAR:ERF's EV-to-Revenue is ranked better than
58.59% of 227 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.02 vs XPAR:ERF: 2.10

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-24), Eurofins Scientific SE's stock price is €56.84. Eurofins Scientific SE's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €32.92. Therefore, Eurofins Scientific SE's PS Ratio for today is 1.73.


Eurofins Scientific SE EV-to-Revenue Historical Data

The historical data trend for Eurofins Scientific SE's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE EV-to-Revenue Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.66 2.82 3.45 2.36 2.16

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.45 - 2.36 - 2.16

Competitive Comparison of Eurofins Scientific SE's EV-to-Revenue

For the Diagnostics & Research subindustry, Eurofins Scientific SE's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's EV-to-Revenue falls into.



Eurofins Scientific SE EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Eurofins Scientific SE's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=13674.350/6514.6
=2.10

Eurofins Scientific SE's current Enterprise Value is €13,674 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eurofins Scientific SE's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €6,515 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurofins Scientific SE  (XPAR:ERF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Eurofins Scientific SE's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=56.84/32.919
=1.73

Eurofins Scientific SE's share price for today is €56.84.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €32.92.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurofins Scientific SE EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (XPAR:ERF) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.

Eurofins Scientific SE (XPAR:ERF) Headlines

From GuruFocus

ERF 8.2% Yield Put into Perspective

By Ilia Frankstein Ilia Frankstein 10-10-2011

Enerplus: Investors Need to Consider This Stock for the Long Run

By Thriftyinvestments Thriftyinvestments 05-13-2015

Why Investors Should Be Cautious About Enerplus in the Short Run

By RHPanalysts RHPanalysts 05-24-2015

Enerplus Corporation Is a Stock to Stay Away From

By MacroConsultants MacroConsultants 04-27-2015

ADVISORY RESEARCH INC Buys 3, Sells 2 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-17-2022